Overview

Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of single-day famciclovir episodic treatment in Black patients with recurrent genital herpes
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
2-Aminopurine
Famciclovir